Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
DESCRIPTION (provided by applicant): A prevailing dogma of leptin research field has attributed the regulation of body weight by leptin exclusively to the hypothalamus of central nervous system (CNS). Here, we demonstrate and propose to further evaluate a genetic example that leptin regulates body weight by DIRECT regulation of fat metabolism in adipocytes in addition to its functions in the hypothalamus. Recently, using a Technical Knock-out (TKO) system, we have engineered a mouse model to display adipocyte-selective deficiency of the leptin receptors. These mutant mice are hereafter referred to as TKO-OBR mice, short for technical knockout of OB-receptors. TKO-OBR mice maintained normal levels of leptin receptors in the hypothalamus. However, the mutant mice developed increased adiposity, hyperinsulinemia, hypertriglyceridemia, impaired glucose tolerance and insulin sensitivity, as well as elevated triglyceride levels in livers and skeletal muscle. A variety of genes involved in regulating fat and glucose metabolism are dysregulated in the white adipose tissue of the mutant mice, such as TNFalpha, AdipoQ, leptin, fatty acid synthase, SREBP-1, glycerol kinase, and beta3-adrenergic receptor. Furthermore, the mutant mice are significantly more sensitive to high-fat feeding with regards to developing obesity and severe insulin resistance than their wild-type littermates. In summary, we have provided the first unequivocal genetic example demonstrating the physiological importance of a direct peripheral effect of leptin in vivo. In this application, we propose a series of studies to further understand the molecular mechanisms by which leptin regulates adiposity and insulin sensitivity through its direct actions in adipocytes. We believe that these studies will provide a possible molecular linkage between adipocyte-selective leptin receptor deficiency and type 2 diabetes.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
01-June-2004
Project End Date
31-May-2008
Budget Start Date
01-June-2006
Budget End Date
31-May-2007
Project Funding Information for 2006
Total Funding
$253,262
Direct Costs
$180,164
Indirect Costs
$73,098
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Diabetes and Digestive and Kidney Diseases
$253,262
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK064383-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK064383-03
Patents
No Patents information available for 5R01DK064383-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK064383-03
Clinical Studies
No Clinical Studies information available for 5R01DK064383-03
News and More
Related News Releases
No news release information available for 5R01DK064383-03
History
No Historical information available for 5R01DK064383-03
Similar Projects
No Similar Projects information available for 5R01DK064383-03